Schlagwortarchiv für: treatment

Antibiotics - Handle with care

„Antibiotics are not a magic drug!“

Health care workers (HCW) play a vital role in preventing the spread of AMR (antimicrobial resistance).  In the course of this years’ Antibiotic Awareness Week (Nov. 14-20), WHO Europe has interviewed HCW from across the European Region about their experiences with antibiotic resistance and how they are working to stop it. The Semmelweis Foundation is […]

Study: Antibiotic treatment of respiratory tract infections (RTIs) offers negligible benefit to affected patients!

Reducing antibiotic prescribing for respiratory tract infections is not linked to an increase in the most serious bacterial complications, such as bacterial meningitis. This has found out a recently in the BMJ published study. We asked study-leader Dr. Martin Gulliford, professor of public health at the King’s College in London. About 60 percent of antibiotics […]

MDR-TB: We have such poor medical treatment to offer that we must resort to surgery!

How effective is surgery as adjunctive therapy for multi-drug resistant tuberculosis (MDR-TB)? This was the subject of a recently published study (PubMed, Jan 2016). About the importance of a combined therapy we asked co-author Dr. Dick Menzies from the Montreal Chest Institute at McGill University. The authors of the study (Fox et al.) examined data […]

Dr. Lloyd Czaplewski

Alternatives to antibiotics – a pipeline portfolio review

In the recently published study „Alternatives to antibiotics – a pipeline portfolio review“ (The Lancet, 12 January 2016) the scientists demonstrate the ten most promising so called „non-compound approaches“. What must be done to develop these „A2A-s“? We asked co-author Dr. Lloyd Czaplewski, Director at Chemical Biology Ventures Limited, UK. Dr. Czaplewski, the study gives […]

Hospital superbug CPE: Over the last two years the epidemiological situation worsened

A recently published report from Eurosurveillance (Nov. 12) about carbapenemase producing enterobacteriaceae (CPE) in Europe states: Cases of this germs are showing a sharp rise. About details concerning this study we asked Dr. Thomas Hauer, medical director of the German consulting centre for hygiene in Freiburg. Mr. Hauer, what does carbapenemase producing mean exactly, and are […]

Study shows: 85 percent of hospital running costs are fixed and cannot be recouped by preventing a healthcare-associated infection!

HAIs have a huge economic burden. In a report from the WHO and also according to a report from the ECDC, these infections account for approximately €7 billion per year in Europe. Cost reduction by preventing HAIs is the aspired aim. But according to a study, 85 percent of hospital running costs are fixed and […]

Montgomery: Further measures must follow!

Around 25.000 people die every year from antibiotic-resistant infections in the European Union. A recent study, launched by the British government, concluded that without action to check antimicrobial resistance, superbugs would cause the deaths of 10 million people every year. How individual countries respond to this phenomenon, and where are still shortcomings? In this article […]

More primary health care centres could reduce infections

The head of the regional health insurance company “Wiener Gebietskrankenkasse” (WGKK), Ingrid Reischl, recently requested more primary health care centres (currently exists only one), which should relieve hospitals. One of the many advantages of the centres would be the lower risk to get infected with dangerous germs. Mrs. Reischl, until the end of 2016 one […]

Hospital infections are costly for hospitals and economies!

Nosocomial infections prolong hospitalization and require more diagnostic and treatment expenses. The systematic implementation of proven prevention measures should get more attention, so the tenor of an event organised by the „Initiative für mehr Sicherheit im OP“ and the „Plattform Patientensicherheit“ in Vienna at the end of May. British data show that the duration of […]

Highly promising Ebola vaccine, developed with Austrian participation, goes into phase II

Research projects to prevent and cure the Ebola virus run at full speed. Among the most promising vaccines is a live vaccine, based on the Vesicular Stomatitis Virus (VSV). Univ.-Prof. Dr. Michael Ramharter from the MedUni Vienna is one of the researches developing this new vaccine. Until now Ebola has killed more than 10.000 people […]